Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Pack Size |
100T |
| CAT No. |
130256004M |
| Application |
Cardiac Marker |
The kit has been designed for the quantitative determination of N-terminal prohormone b-type natriuretic peptide (NT-proBNP) in human serum. The method can be used for samples over the range of 0-10000 pg/ml. The test has to be performed on the MAGLUMI chemiluminescence immunoassay (CLIA) fully auto analyzer (Including MAGLUMI 1000, MAGLUMI 2000, MAGLUMI 2000 Plus and new developed model).
High Throughput, Rapid ResultsWith a test throughput of up to 180 tests per hour and an assay time of less than 30 minutes per analysis, the MAGLUMI NT-proBNP kit streamlines laboratory workflow. Its fully automated operation with MAGLUMI analyzers minimizes hands-on time, enabling efficient and timely reporting for clinics and hospitals.
Clinically Relevant and AccurateDesigned with high sensitivity and specificity, the reagent kit detects NT-proBNP within a measurement range of 10-35,000 pg/mL. The included positive and negative controls help ensure accuracy and reproducibility of test results, supporting confident clinical decisions in heart failure management.
User-Friendly and ReliableSupplied as a ready-to-use reagent kit with a 12-month shelf life, the MAGLUMI NT-proBNP assay maintains calibration stability for up to one month (on-analyzer). Storage conditions are straightforward (2C-8C, do not freeze), and the components are compatible with all MAGLUMI series analyzers, making the kit easy to integrate in clinical laboratories.
FAQ's of Snibe MAGLUMI NT-proBNP (CLIA):
Q: How much sample volume is required for each NT-proBNP test with the MAGLUMI kit?
A: A minimum of 30 L of human serum or plasma (with EDTA, heparin, or citrate anticoagulant) is needed for each test using the MAGLUMI NT-proBNP (CLIA) reagent kit.
Q: What are the key steps in performing the NT-proBNP assay with this kit?
A: The assay follows an automated workflow on compatible MAGLUMI immunoassay analyzers: load the patient samples and reagents, start the run, and review results displayed on the analyzer. Calibration and controls supplied with the kit should be used as per the manufacturer's instructions for quality assurance.
Q: When should the calibration be performed for the NT-proBNP kit, and how stable is it?
A: Calibration should be carried out according to the analyzer guidelines, typically when first using a new kit or after significant maintenance. The calibration remains stable for up to one month on the analyzer, depending on storage and usage conditions.
Q: Where can the MAGLUMI NT-proBNP (CLIA) kit be used, and who is it intended for?
A: This reagent kit is designed for use in clinical laboratories by qualified professionals. It is compatible with MAGLUMI series immunoassay analyzers and is not intended for point-of-care or home use.
Q: What are the primary clinical applications and benefits of measuring NT-proBNP with this kit?
A: Quantifying NT-proBNP aids in the diagnosis and management of heart failure and related cardiac conditions. The high sensitivity and specificity of the kit, along with rapid and automated testing, support reliable clinical decision-making and efficient patient care.
Q: How should the kit be stored to maintain its effectiveness throughout the shelf life?
A: Store the MAGLUMI NT-proBNP (CLIA) kit at 2C-8C. Do not freeze the reagents. Adhering to the recommended storage instructions ensures the 12-month shelf life and optimal test performance.